HUM vs ROIV · P/E 39, rev $129.66B vs rev $29.1M
Humana Inc (HUM) versus Roivant Sciences Ltd (ROIV) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported ROIV revenue for 2025-03-31 was $29.1M. Net income was -$356.7M. Revenue was down 11.2% from 2024-03-31 to 2025-03-31. ROIV currently screens at market cap $7.47B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. ROIV currently screens at market cap $7.47B.
Not investment advice. Open the HUM and ROIV stock pages for the full models.
Not investment advice.